Relationship of leptin level with metabolic disorders and hypertension in Japanese type 2 diabetes mellitus patients

被引:40
作者
Asakawa, H [1 ]
Tokunaga, K [1 ]
Kawakami, F [1 ]
机构
[1] Itami City Hosp, Dept Internal Med, Itami, Hyogo 6648540, Japan
关键词
leptin; metabolic disorder; visceral fat; subcutaneous fat; retinopathy; nephropathy; neuropathy; macroangiopathy; microangiopathy;
D O I
10.1016/S1056-8727(00)00145-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Leptin is considered to play an important role in the regulation of body weight and metabolism in obese individuals. However, the relationship of leptin with metabolic disorders or vascular complications in type 2 diabetic patients has yet to be elucidated. In this study, we investigated the association of leptin levels with clinical parameters (glycemic control, lipid levels, abdominal fat distribution) and - investigated the leptin levels of diabetic patients with and without vascular complications in Japanese diabetic patients. In male and female patients, leptin levels were significantly associated with body mass index (BMI), percent body fat, insulin level, triglyceride (TG) level, total abdominal fat area (TFA), visceral fat area (VFS), and subcutaneous fat area (SFA). Only in male patients, leptin levels were inversely correlated with HDL-cholesterol, fasting plasma glucose (FPG), and HbA(IC). Leptin levels in male and female patients with hypertension were higher than in those without hypertension. Leptin levels of both males and females with angiopathy were not statistically different from those without angiopathy. In conclusion, leptin is involved in various metabolic disorders and hypertension, and we speculate that it may not be strongly associated with vascular complications in Japanese diabetic individuals. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:57 / 62
页数:6
相关论文
共 32 条
[1]  
Agata J, 1997, AM J HYPERTENS, V10, P1171
[2]   Leptin, the product of Ob gene, promotes angiogenesis [J].
Bouloumié, A ;
Drexler, HCA ;
Lafontan, M ;
Busse, R .
CIRCULATION RESEARCH, 1998, 83 (10) :1059-1066
[3]   Serum immunoreactive leptin concentrations in normal-weight and obese humans [J].
Considine, RV ;
Sinha, MK ;
Heiman, ML ;
Kriauciunas, A ;
Stephens, TW ;
Nyce, MR ;
Ohannesian, JP ;
Marco, CC ;
McKee, LJ ;
Bauer, TL ;
Caro, JF .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (05) :292-295
[4]   INSULIN RESISTANCE - A MULTIFACETED SYNDROME RESPONSIBLE FOR NIDDM, OBESITY, HYPERTENSION, DYSLIPIDEMIA, AND ATHEROSCLEROTIC CARDIOVASCULAR-DISEASE [J].
DEFRONZO, RA ;
FERRANNINI, E .
DIABETES CARE, 1991, 14 (03) :173-194
[5]   Elevated serum leptin concentrations in type 2 diabetic patients with microalbuminuria and macroalbuminuria [J].
Fruehwald-Schultes, B ;
Kern, W ;
Beyer, J ;
Forst, T ;
Pfützner, A ;
Peters, A .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1999, 48 (10) :1290-1293
[6]  
GAAL LFV, 1999, INT J OBESITY S1, V23, P29
[7]  
Gavin JR, 1997, DIABETES CARE, V20, P1183
[8]   The relationship between leptin and the insulin resistance syndrome is disturbed in type 2 diabetic subjects with parasympathetic neuropathy [J].
Gottsäter, A ;
Ahrén, B ;
Sundkvist, G .
DIABETES CARE, 1999, 22 (11) :1913-1914
[9]   Leptin concentrations in diabetic and nondiabetic Mexican-Americans [J].
Haffner, SM ;
Stern, MP ;
Miettinen, H ;
Wei, M ;
Gingerich, RL .
DIABETES, 1996, 45 (06) :822-824
[10]   WEIGHT-REDUCING EFFECTS OF THE PLASMA-PROTEIN ENCODED BY THE OBESE GENE [J].
HALAAS, JL ;
GAJIWALA, KS ;
MAFFEI, M ;
COHEN, SL ;
CHAIT, BT ;
RABINOWITZ, D ;
LALLONE, RL ;
BURLEY, SK ;
FRIEDMAN, JM .
SCIENCE, 1995, 269 (5223) :543-546